TTLA EClips

• TTLA Home • Search Litigation Bank • About

October 26, 2007

Fund Proposed for Survivors of Bridge Collapse

Extent of Stolen Credit Data Grows

Jury Awards Damages Against Maine Hospital

Appellate Court Supports Firm on Fees

BP Settles Charges, Individuals Could be Held Accountable

Ground Zero Worker Died from Drug Misuse Not Dust, Examiner Says

Heart Drug Linked to Death Risk, FDA Says

 

 

This Service Sponsored Exclusively by
The James Street Group

A Member Service of
Texas Trial Lawyers Association

 

 

ANNOUNCEMENTS

 

 

LAWS/CASES

 

Fund Proposed for Survivors of Bridge Collapse

Survivors of the Minneapolis bridge collapse are asking Minnesota lawmakers to create a fund similar to the one established by Congress following the September 11 terrorist attacks. The proposed compensation fund would require those affected by the collapse to give up their right to pursue claims against the state in order to receive compensation for pain and suffering, injuries, medical costs and economic losses. Minnesota law caps liability at $1 million per incident and $300,000 per individual.  Martiga LohnLA Times  10/25/2007

Read Article: LA Times    

 

Extent of Stolen Credit Data Grows

The amount of credit card data stolen from discount retailer TJX has grown to 94 million Visa and MasterCard accounts. Court filings in several lawsuits filed by banks against TJX suggest that losses from Visa cards alone range from $68 million to $83 million. Depositions indicate that the amount of stolen data was more than twice that initially reported by TJX.  Mark Jewell, TheWashington Post  10/25/2007

Read Article: The Washington Post    

 

Jury Awards Damages Against Maine Hospital

A severely brain damaged boy and his mother received almost $8 million in damages Thursday in a lawsuit against a Maine hospital and one of its midwives. In the complaint, Sasha Emond contended that her midwife andCentral Maine Medical Center failed to recommend an emergency cesarean section during the birth. The woman’s child was born with cerebral palsy caused by lack of blood and oxygen to his brain.  AP, Boston Globe  10/25/2007

Read Article: Boston Globe    

 

Appellate Court Supports Firm on Fees

Earlier this month, the 7th Circuit Court of Appeals raised the possibility that class action firm Milberg Weiss had been undercompensated in a settlement with a defunct internet consulting company. The appellate court’s ruling raised questions about how the trial judge determined attorney fees for the $18 million settlement. The panel points out that the judge should have considered market prices for legal services when determining the fees.  Ameet Sachdev,Chicago Tribune  10/26/2007

Read Article: Chicago Tribune    

 

BP Settles Charges, Individuals Could be Held Accountable

Energy giant BP has agreed to pay more than $373 million in fines to settle criminal charges stemming from a deadly explosion at a Texas refinery, propane trading manipulation and an Alaskan oil spill. However, individuals employed by BP who had knowledge of safety and regulatory violations could still face charges, a U.S. attorney said. Investigations into the 2005 Texas Cityrefinery blast revealed rampant safety violations at the plant.  Kristen Hays,Houston Chronicle  10/26/2007

Read Article: Houston Chronicle    

 

ISSUES

 

Ground Zero Worker Died from Drug Misuse Not Dust, Examiner Says

The cause of death of a former New York detective remains a matter of heated debate despite a newly released conclusion by the New York Citymedical examiner. According to the medical examiners report, James Zadroga died from the misuse of prescription drugs rather than toxic contaminants from ground zero, as other medical examiners had concluded. An attorney for the family disputed the conclusion that the detective had abused drugs.  Anthony DePalma, The New York Times  10/26/2007

Read Article: The New York Times    

 

PRODUCTS

 

Heart Drug Linked to Death Risk, FDA Says

A Bayer AG drug used to prevent excessive bleeding during heart surgery has been found to increase the risk of death, the Food and Drug Administration said Thursday. The FDA announcement comes on the heels of a Canadian study that was halted after researchers determined the drug, Trasylol, increased the risk of death compared to other drugs. Health officials said they would evaluate possible label changes for drug along with other regulatory actions.  AP, The Washington Post  10/25/2007

Read Article: The Washington Post    


 

Published by TRIALSMITH, Litigation Tools for Trial Lawyers